The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Reproduce the IMpower133 Clinical Trial Results
The impower133 package provides functions to reproduce the results of the IMpower133 clinical trial (Horn et al., 2018, NEJM), a phase III randomized controlled trial evaluating atezolizumab plus chemotherapy versus placebo plus chemotherapy in extensive-stage small-cell lung cancer.
This package was developed as a course project for the Biostatistics course at East China Normal University.
install.packages(“impower133”)
Or install the development version from GitHub:
remotes::install_github(“fanfande131/impower133”)
rtriang() - Triangular distribution random number generator
simulate_impower133() - Simulate complete ITT population with baseline, efficacy, and safety data
reconstruct_survival() - Reconstruct individual patient data from published K-M curves
analyze_survival() - Analyze survival data and print key statistics
plot_survival() - Plot K-M survival curves for OS or PFS
make_table1() - Generate Table 1: Baseline characteristics
make_table2() - Generate Table 2: Response rate and disease progression
make_table3() - Generate Table 3: Adverse events
plot_figure2c() - Generate Figure 2C: Subgroup forest plot
See inst/examples/test_impower133.R for a complete
example. Simulated data, output figures (tables and plots), and the
reconstructed IPD data are also available in
inst/examples/.
The individual patient data was reconstructed from published Kaplan-Meier curves using the IPDfromKM web application:
https://biostatistics.mdanderson.org/shinyapps/IPDfromKM/
Method reference: Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21(1):111.
Horn L, Mansfield AS, Szczesna A, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379:2220-2229. doi:10.1056/NEJMoa1809064
MIT
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.